Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section

PHASE1CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Post Spinal Shivering
Interventions
DRUG

Dexmedetomidine Injection [Precedex],,,

patients will receive 0.5ml (10 µg) Dexmedetomidine as an adjuvant to 2.2ml hyperbaric Bupivacaine hydrochloride 0.5%

DRUG

Fentanyl

will be given 0.5 ml of one ampoule (2ml) of 100µg fentanyl (Fentanyl Hameln® 0.1mg/2ml - Sunny pharm) equivalent to 25 µg fentanyl as an adjuvant to 2.2ml hyperbaric Bupivacaine hydrochloride 0.5%

Trial Locations (1)

11111

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06318546 - Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section | Biotech Hunter | Biotech Hunter